Extract from the Register of European Patents

EP Citations: EP4329757

Cited inSearch
Type:Patent literature
Publication No.:EP4144732  [E]
 (SHANGHAI RINGENE BIOPHARMA CO LTD et al.) [E] 1-3,5,13-15 * examples 1-4, 11-14, 18 *
Type:Patent literature
Publication No.:WO2021107160  [XPI]
 (TAIHO PHARMACEUTICAL CO LTD et al.) [XP] 1-3,5,13-15 * page 147; example -; table 1 *[I] 4,6-12
Type:Patent literature
Publication No.:CN112110918  [XI]
 (GENFLEET THERAPEUTICS SHANGHAI INC et al.) [X] 1-5,13-15 * paragraph [0393] *[I] 6-12
Type:Patent literature
Publication No.:WO2020097537  [XI]
 (GENENTECH INC et al.) [X] 1-5,13-15 * paragraph [0439] *[I] 6-12
Type:Patent literature
Publication No.:WO2016049568  [XI]
 (ARAXES PHARMA LLC et al.) [X] 1-5,13-15 * examples 71, 72 *[I] 6-12
Type:Patent literature
Publication No.:WO2017172979  [XI]
 (ARAXES PHARMA LLC et al.) [X] 1-5,13-15 * examples 112, 120, 131, 136, 138, 147; table 1 *[I] 6-12
Type:Patent literature
Publication No.:WO2018218070  [XI]
 (ARAXES PHARMA LLC et al.) [X] 1-5,13-15 * page 175, line 12 - page 203, line 11 *[I] 6-12
Cited inInternational search
Type:Patent literature
Publication No.:US2020352931  [A]
 (STEENECK CHRISTOPH et al.) [A] 1-3 * entire document *
Type:Patent literature
Publication No.:US2019119216  [A]
 (CHERNEY EMILY CHARLOTTE et al.) [A] 1-3 * entire document *
Type:Patent literature
Publication No.:WO2013144737  [A]
 (RHIZEN PHARMACEUTICALS SA et al.) [A] 1-3 * entire document *